Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
896
archived clinical trials in
Gastroesophageal Reflux Disease

YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Rejendra Prasad Gupta
2380
mi
from 98109
Trenton, NJ
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Rejendra Prasad Gupta
2380
mi
from 98109
Trenton, NJ
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Vitaly Fishbein
2387
mi
from 98109
West Orange, NJ
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Vitaly Fishbein
2387
mi
from 98109
West Orange, NJ
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Wieslaw Ignatowicz
2404
mi
from 98109
Brooklyn, NY
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Wieslaw Ignatowicz
2404
mi
from 98109
Brooklyn, NY
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Eugene Bonapace
2415
mi
from 98109
Great Neck, NY
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Eugene Bonapace
2415
mi
from 98109
Great Neck, NY
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. James Grendell
2418
mi
from 98109
Mineola, NY
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. James Grendell
2418
mi
from 98109
Mineola, NY
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. William Harlan
2188
mi
from 98109
Asheville, NC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. William Harlan
2188
mi
from 98109
Asheville, NC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. John Poulos
2378
mi
from 98109
Fayetteville, NC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. John Poulos
2378
mi
from 98109
Fayetteville, NC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Peter Eweje
2460
mi
from 98109
Jacksonville, NC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Peter Eweje
2460
mi
from 98109
Jacksonville, NC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Charles Barish
2357
mi
from 98109
Raleigh, NC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Charles Barish
2357
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. William Gramley
2457
mi
from 98109
Wilmington, NC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. William Gramley
2457
mi
from 98109
Wilmington, NC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Robert Kindel
1965
mi
from 98109
Cincinnati, OH
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Robert Kindel
1965
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Gregory Cooper
2024
mi
from 98109
Cleveland, OH
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Gregory Cooper
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Gary Falk
2024
mi
from 98109
Cleveland, OH
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Gary Falk
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Michael Grossman
1518
mi
from 98109
Oklahoma City, OK
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Michael Grossman
1518
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Michael Mirhej, MD
247
mi
from 98109
Eugene, OR
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Michael Mirhej, MD
247
mi
from 98109
Eugene, OR
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Nayan Shah
2304
mi
from 98109
Eynon, PA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Nayan Shah
2304
mi
from 98109
Eynon, PA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Robert Fisher
2373
mi
from 98109
Philadelphia, PA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Robert Fisher
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Cynthia Strout
2426
mi
from 98109
Mount Pleasant, SC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Cynthia Strout
2426
mi
from 98109
Mount Pleasant, SC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Robert Smith, MD
2293
mi
from 98109
Saluda, SC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Robert Smith, MD
2293
mi
from 98109
Saluda, SC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Richard Krause
2088
mi
from 98109
Chattanooga, TN
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Richard Krause
2088
mi
from 98109
Chattanooga, TN
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Mark Swaim
1900
mi
from 98109
Jackson, TN
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Mark Swaim
1900
mi
from 98109
Jackson, TN
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
George James, MD
1970
mi
from 98109
Nashville, TN
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
George James, MD
1970
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Ronald Pruitt
1969
mi
from 98109
Nashville, TN
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Ronald Pruitt
1969
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. James Race
1680
mi
from 98109
Dallas, TX
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. James Race
1680
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Sardar Khan, MD
1874
mi
from 98109
Houston, TX
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Sardar Khan, MD
1874
mi
from 98109
Houston, TX
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Ralph Alhalel, MD
1976
mi
from 98109
McAllen, TX
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Ralph Alhalel, MD
1976
mi
from 98109
McAllen, TX
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Daniel Pambianco
2286
mi
from 98109
Charlottesville, VA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Daniel Pambianco
2286
mi
from 98109
Charlottesville, VA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Mark Ringold
2228
mi
from 98109
Christiansburg, VA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Mark Ringold
2228
mi
from 98109
Christiansburg, VA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Vinod Rustgi, MD
2312
mi
from 98109
Fairfax, VA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Vinod Rustgi, MD
2312
mi
from 98109
Fairfax, VA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Michael Schmalz
1687
mi
from 98109
Milwaukee, WI
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Michael Schmalz
1687
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease
Quality of Life in Barrett's Esophagus and GERD:GERD Symptoms, Perception of Cancer Risk, and Actual Cancer Risk
Status: Enrolling
Updated:  1/16/2018
Kansas City VA Medical Center
1506
mi
from 98109
Kansas City, MO
Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease
Quality of Life in Barrett's Esophagus and GERD:GERD Symptoms, Perception of Cancer Risk, and Actual Cancer Risk
Status: Enrolling
Updated: 1/16/2018
Kansas City VA Medical Center
1506
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Status: Enrolling
Updated:  1/16/2018
Topeka VA Medical Center
1456
mi
from 98109
Topeka, KA
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Status: Enrolling
Updated: 1/16/2018
Topeka VA Medical Center
1456
mi
from 98109
Topeka, KA
Click here to add this to my saved trials
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Status: Enrolling
Updated:  1/16/2018
Kansas City VA Medical Center
1506
mi
from 98109
Kansas City, MO
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Status: Enrolling
Updated: 1/16/2018
Kansas City VA Medical Center
1506
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
Pilot Randomized Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal and Gastric Microbiome
Status: Enrolling
Updated:  1/25/2018
Columbia University Medical Center
2401
mi
from 98109
New York, NY
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
Pilot Randomized Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal and Gastric Microbiome
Status: Enrolling
Updated: 1/25/2018
Columbia University Medical Center
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Status: Enrolling
Updated:  2/5/2018
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Status: Enrolling
Updated: 2/5/2018
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Status: Enrolling
Updated:  2/5/2018
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Status: Enrolling
Updated: 2/5/2018
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
Status: Enrolling
Updated:  2/16/2018
Univ of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
Status: Enrolling
Updated: 2/16/2018
Univ of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
A Phase 2, Double-Blind, 12 Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules in Pediatric Subjects Aged 1 to 11 Years With Symptomatic Nonerosive Gastroesophageal Reflux Disease
Status: Enrolling
Updated:  3/6/2018
University of Louisville
1938
mi
from 98109
Louisville, KY
A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
A Phase 2, Double-Blind, 12 Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules in Pediatric Subjects Aged 1 to 11 Years With Symptomatic Nonerosive Gastroesophageal Reflux Disease
Status: Enrolling
Updated: 3/6/2018
University of Louisville
1938
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
Childrens Hospital Los Angeles
957
mi
from 98109
Los Angeles, CA
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
Childrens Hospital Los Angeles
957
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
University of Louisville
1938
mi
from 98109
Louisville, KY
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
University of Louisville
1938
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
Johns Hopkins University School of Medicine
2329
mi
from 98109
Baltimore, MD
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
Johns Hopkins University School of Medicine
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
Michigan Pediatric GI Center
1884
mi
from 98109
Flint, MI
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
Michigan Pediatric GI Center
1884
mi
from 98109
Flint, MI
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
ProMedica Toledo Children's Hospital
1925
mi
from 98109
Toledo, OH
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
ProMedica Toledo Children's Hospital
1925
mi
from 98109
Toledo, OH
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
Cook Children's Medical Center
1660
mi
from 98109
Fort Worth, TX
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
Cook Children's Medical Center
1660
mi
from 98109
Fort Worth, TX
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
Hadassah University Hospital - Ein Kerem
6775
mi
from 98109
Jerusalem,
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
Hadassah University Hospital - Ein Kerem
6775
mi
from 98109
Jerusalem,
Click here to add this to my saved trials
Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes
Automated Evaluation of Gastrointestinal Symptoms (AEGIS): A Pragmatic Clinical Trial Evaluating the Impact of AEGIS on Clinical Outcomes
Status: Enrolling
Updated:  4/29/2018
Cedars-Sinai Medical Center
962
mi
from 98109
Los Angeles, CA
Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes
Automated Evaluation of Gastrointestinal Symptoms (AEGIS): A Pragmatic Clinical Trial Evaluating the Impact of AEGIS on Clinical Outcomes
Status: Enrolling
Updated: 4/29/2018
Cedars-Sinai Medical Center
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials